시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 위축성 설염 치료 시장 보고서(2025년)
Atrophic Glossitis Treatment Global Market Report 2025
상품코드 : 1760469
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,319,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,134,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,949,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

위축성 설염 치료 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 습격적인 치료 옵션 수요 증가가 견인할 것으로 보입니다. 예측 기간의 주요 동향으로는 국소 치료의 혁신, 맞춤형 영양 보조 식품의 개발, 구강 케어 치료의 기술 진보, 설염의 진단에 있어서의 AI와 머신러닝의 이용, 위축성 설염 치료의 종합적 구강 케어 관리에의 통합 등을 들 수 있습니다.

영양 결핍증의 유병률 상승은 향후 몇 년간의 위축성 설염 치료 시장의 성장을 가속할 것으로 예측됩니다. 영양 결핍은 사람의 식단에 비타민, 미네랄, 단백질과 같은 필수 영양소가 부족할 때 발생하며, 이는 다양한 건강 합병증을 초래합니다. 영양 부족의 비율이 증가하고 있는 주된 원인은 식생활의 혼란에 있어, 영양소가 적은 가공 식품을 섭취하는 사람이 늘고 있기 때문에 건강 전반에 필요한 필수 비타민이나 미네랄의 섭취량이 부족해지고 있습니다. 위축성 설염 치료는 철분, 엽산, 비타민 B12 등 혀 조직의 건강을 회복하고 점막의 위축을 방지하기 위해 중요한 영양소를 보급함으로써 이러한 부족을 해소합니다. WHO는 2023년에 15-49세 여성의 30.7%, 같은 연령층의 임산부의 35.5%가 빈혈에 앓고 있다고 보고했습니다.

또한, 자가면역질환의 유병률 증가도 시장 확대에 기여할 것으로 보여지고 있습니다. 유전적 소인과 면역조절을 방해하는 환경요인의 조합에 의한 것입니다. 예를 들어, 2024년 11월에 Versorgungsatlas.de라는 조직이 보고한 바에 따르면, 2022년 독일의 피보험자 7,324만 1,305명 중 630만 4,340명이 적어도 하나의 자가면역질환으로 진단되었으며, 유병률은 8.61%였습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Atrophic glossitis treatment refers to medical approaches aimed at managing the inflammation and degeneration of the tongue's papillae, which leads to a smooth, glossy, and often painful tongue. Treatment focuses on identifying and addressing underlying causes, often involving nutritional deficiencies (such as iron, vitamin B12, or folate), infections, autoimmune conditions, or systemic disorders such as celiac disease.

Primary treatment types include medications, topical treatments, nutritional supplements, and oral care products. Medications are used to treat underlying issues such as infections, inflammation, or deficiencies, helping to relieve symptoms and promote healing of the tongue. Depending on symptoms, treatments target inflammation, discoloration, itching, and burning sensations, and are distributed through direct tenders, hospital pharmacies, retail pharmacies, online pharmacies, and other channels. These treatments are utilized by end users such as hospitals, ambulatory surgical centers, and home care providers.

The atrophic glossitis treatment market research report is one of a series of new reports from The Business Research Company that provides atrophic glossitis treatment market statistics, including atrophic glossitis treatment industry global market size, regional shares, competitors with a atrophic glossitis treatment market share, atrophic glossitis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the atrophic glossitis treatment industry. This atrophic glossitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The atrophic glossitis treatment market size has grown strongly in recent years. It will grow from $1.74 billion in 2024 to $1.88 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth during the historic period can be attributed to greater awareness of oral health, the rising prevalence of nutritional deficiencies, an expanding geriatric population, the increasing popularity of online pharmacies, and a growing incidence of vitamin deficiencies.

The atrophic glossitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. Growth in the forecast period is expected to be driven by rising healthcare expenditures, increased adoption of dietary supplements, advancements in diagnostic techniques for oral conditions, a growing elderly population at higher risk for glossitis, and increasing demand for non-invasive treatment options. Key trends in the forecast period include innovations in topical treatments, development of tailored nutritional supplements, technological progress in oral care treatments, the use of AI and machine learning in diagnosing glossitis, and the integration of atrophic glossitis treatments into comprehensive oral care management.

The rising prevalence of nutritional deficiencies is expected to drive the growth of the atrophic glossitis treatment market in the coming years. Nutritional deficiencies occur when a person's diet lacks essential nutrients such as vitamins, minerals, and proteins, leading to various health complications. The increasing rate of nutritional deficiencies is mainly attributed to poor dietary habits, with more individuals consuming processed foods that are low in nutrients, resulting in an insufficient intake of essential vitamins and minerals necessary for overall health. Atrophic glossitis treatment helps address these deficiencies by replenishing key nutrients such as iron, folate, and vitamin B12, which are crucial for restoring tongue tissue health and preventing further mucosal atrophy. For example, in May 2025, the World Health Organization reported that in 2023, 30.7% of women aged 15-49 and 35.5% of pregnant women in the same age group suffered from anemia. As a result, the growing prevalence of nutritional deficiencies is fueling the expansion of the atrophic glossitis treatment market.

The increasing prevalence of autoimmune diseases is also expected to contribute to the market growth. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy tissues. The rise in autoimmune diseases is largely due to a combination of genetic predisposition and environmental factors that disrupt immune regulation. Atrophic glossitis treatment addresses both the nutritional deficiencies and inflammation often associated with autoimmune diseases, helping to improve immune system function and relieve symptoms. For instance, in November 2024, the organization Versorgungsatlas.de reported that in 2022, 6,304,340 out of 73,241,305 insured individuals in Germany were diagnosed with at least one autoimmune disease, reflecting a raw prevalence rate of 8.61%. Consequently, the increasing prevalence of autoimmune diseases is driving the demand for atrophic glossitis treatment.

Rising healthcare expenditure is another factor propelling the growth of the atrophic glossitis treatment market. Healthcare expenditure refers to the total amount spent on health services and products, including hospital care, physician services, nursing care, medications, and public health initiatives. This expenditure is growing due to rapid advancements in medical technology, which lead to higher costs for diagnoses and treatments, as newer tools and procedures require significant investment and specialized training. Healthcare spending plays a crucial role in the atrophic glossitis treatment market by funding necessary diagnostic tests and specialized treatments, including nutritional supplementation and management of underlying conditions. Additionally, increased spending ensures better access to healthcare professionals who can create personalized care plans. For example, in December 2023, the Centers for Medicare & Medicaid Services reported a 4.1% increase in U.S. healthcare spending in 2022, reaching $4.5 trillion, up from a 3.2% growth rate in 2021. As a result, the rise in healthcare expenditure is further fueling the growth of the atrophic glossitis treatment market.

Major players in the atrophic glossitis treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, Sanofi S.A., GSK plc, Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals PLC, Endo International plc, Rech Chemical Co. Ltd., AdvaCare Pharma USA LLC, Crown Technology Inc., Chemland Group Co. Ltd., Himalayan Organics, Indexim International Private Limited, Leo Nutriscience LLP, Rass Biosolution Private Limited, Torso Healthcare Private Limited, and Carbamide Forte.

North America was the largest region in the atrophic glossitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in atrophic glossitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the atrophic glossitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atrophic glossitis treatment market consists of revenues earned by entities by providing services such as diagnosis services, nutritional counseling, prescription medication services, monitoring and follow-up care, and patient education and awareness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrophic glossitis treatment market also includes sales of natural vitamin B12, solgar iron tablets, orabase with hydrocortisone, nystatin oral suspension, amoxicillin, and metronidazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atrophic Glossitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atrophic glossitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for atrophic glossitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atrophic glossitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Atrophic Glossitis Treatment Market Characteristics

3. Atrophic Glossitis Treatment Market Trends And Strategies

4. Atrophic Glossitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Atrophic Glossitis Treatment Growth Analysis And Strategic Analysis Framework

6. Atrophic Glossitis Treatment Market Segmentation

7. Atrophic Glossitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Atrophic Glossitis Treatment Market

9. China Atrophic Glossitis Treatment Market

10. India Atrophic Glossitis Treatment Market

11. Japan Atrophic Glossitis Treatment Market

12. Australia Atrophic Glossitis Treatment Market

13. Indonesia Atrophic Glossitis Treatment Market

14. South Korea Atrophic Glossitis Treatment Market

15. Western Europe Atrophic Glossitis Treatment Market

16. UK Atrophic Glossitis Treatment Market

17. Germany Atrophic Glossitis Treatment Market

18. France Atrophic Glossitis Treatment Market

19. Italy Atrophic Glossitis Treatment Market

20. Spain Atrophic Glossitis Treatment Market

21. Eastern Europe Atrophic Glossitis Treatment Market

22. Russia Atrophic Glossitis Treatment Market

23. North America Atrophic Glossitis Treatment Market

24. USA Atrophic Glossitis Treatment Market

25. Canada Atrophic Glossitis Treatment Market

26. South America Atrophic Glossitis Treatment Market

27. Brazil Atrophic Glossitis Treatment Market

28. Middle East Atrophic Glossitis Treatment Market

29. Africa Atrophic Glossitis Treatment Market

30. Atrophic Glossitis Treatment Market Competitive Landscape And Company Profiles

31. Atrophic Glossitis Treatment Market Other Major And Innovative Companies

32. Global Atrophic Glossitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atrophic Glossitis Treatment Market

34. Recent Developments In The Atrophic Glossitis Treatment Market

35. Atrophic Glossitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기